Intermittent protein restriction before but not after the onset of diabetic kidney disease attenuates disease progression in mice

Front Nutr. 2024 Jun 26:11:1383658. doi: 10.3389/fnut.2024.1383658. eCollection 2024.

Abstract

Background: High dietary protein intake exacerbates proteinuria in individuals with diabetic kidney disease (DKD). However, studies on the impacts of low protein diet (LPD) on DKD have yielded conflicting results. Furthermore, patient compliance to continuous protein restriction is challenging.

Objective: The current study aims to investigate the effects of intermittent protein restriction (IPR) on disease progression of DKD.

Methods: Diabetic KK-Ay mice were used in this study. For the IPR treatment, three consecutive days of LPD were followed by four consecutive days of normal protein diet (NPD) within each week. For early intervention, mice received IPR before DKD onset. For late intervention, mice received IPR after DKD onset. In both experiments, age-matched mice fed continuous NPD served as the control group. Kidney morphology, structure and function of mice in different groups were examined.

Results: Intermittent protein restriction before DKD onset ameliorated pathological changes in kidney, including nephromegaly, glomerular hyperfiltration, tubular injuries and proteinuria, without improving glycemic control. Meanwhile, IPR initiated after DKD onset showed no renoprotective effects despite improved glucose homeostasis.

Conclusion: Intermittent protein restriction before rather than after DKD onset protects kidneys, and the impacts of IPR on the kidneys are independent of glycemic control. IPR shows promise as an effective strategy for managing DKD and improving patient compliance.

Keywords: cell-cell junction; diabetic kidney disease; early intervention; intermittent protein restriction; low protein diet.

Grants and funding

The authors declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Key Research and Development Program of China (2019YFA0802500), the National Natural Science Foundation of China (92057107, 32200965, and 32371234), Collaborative Innovation Program of Shanghai Municipal Health Commission (2020CXJQ01), the Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-032A), the Tianjin Natural Science Foundation (Grant Nos. 21JCQNJC00460 and 22JCQNJC01330), the Special Foundation for Beijing Tianjin Hebei Basic Research Cooperation (J210008, 21JCZXJC00170, and H2021202008), and the Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital (Nos. ZXY-ZDSYS2021-4, ZXY-ZDSYSZD2023-1, ZXY-YJJ2020-5, and ZXY-ZDSYSZD2021-2).